DiaSorin S.p.A.

DIA

IT0003492391

Medical Equipment, Supplies & Distribution

Market Closed - Borsa Italiana Other stock markets 11:44:59 2024-05-31 am EDT			5-day change	1st Jan Change
98.94 ^EUR	-1.70%		+0.65%	+6.11%

May. 30	Funds move on Banco BPM, DiaSorin and Webuild.	AN
May. 30	Futures bearish; focus on European data	AN

Funds move on DiaSorin and Leonardo on the Mib.

May 16, 2024 at 09:52 am EDT

(Alliance News) - The following net short positions are the latest provided by Consob and updated as of May 15, 2024:

----------

FTSE MIB

----------

Millennium International Management raises short position on DiaSorin to 0.54% from 0.48%

----------

Marshall Wace files short position on Leonardo to 1.18% from 1.2%

----------

FTSE Italy Mid Cap

----------

Voleon Capital Management cuts short position on Juventus Football Club to 0.58% from 0.69%

----------

Silver Point Capital cuts short position on OVS to 0.49% from 0.73%

----------

By Claudia Cavaliere, Alliance News reporter

Comments and questions to redazione@alliancenews.com

Go to the original article.
Legal disclaimer

Stocks mentioned in the article

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
FTSE MIB INDEX	34,492 PTS	+0.13%	+0.00%	-
STOXX ITALY 20 (EUR)	1,570 PTS	+0.24%	-0.00%	-
MSCI ITALY (STRD)	385.3 USD	+0.29%	+0.14%	-
STOXX ITALY 45 (EUR)	155.6 PTS	+0.08%	+0.03%	-
STOXX ITALY TMI (EUR)	155.4 PTS	+0.10%	+0.08%	-
DIASORIN S.P.A.	98.94 EUR	-1.70%	+0.65%	5.72B
SILVER	30.38 USD	-2.56%	+0.77%	-
LEONARDO S.P.A.	23.57 EUR	+2.08%	+0.43%	14.71B
OVS S.P.A.	2.726 EUR	+0.22%	+1.72%	749M
MILLENNIUM GROUP INTERNATIONAL HOLDINGS LIMITED	1.372 USD	-0.60%	-0.60%	15.43M

Latest news about DiaSorin S.p.A.

Funds move on Banco BPM, DiaSorin and Webuild.	May. 30	AN
Futures bearish; focus on European data	May. 30	AN
Stock markets in the red; DiaSorin snap on Mib.	May. 29	AN
Indices flat; Newlat runs after Princes acquisition.	May. 27	AN
Citadel Advisors moves on Saipem and Biesse.	May. 21	AN
DiaSorin takes over shares for more than EUR8 million	May. 20	AN
DiaSorin receives clearance from US FDA for NxTAG panel	May. 17	AN
Funds move on DiaSorin and Leonardo on the Mib.	May. 16	AN
Futures bullish; traders believe in Fed cut	May. 16	AN
Mib above 35,300 points; Interpump the best	May. 15	AN
Mib up with banks; A2A rises after quarterly report	May. 14	AN
Stock markets contrasted; DiaSorin still pushes on Mib.	May. 14	AN
Lists expected unchanged ahead of opening	May. 14	AN
Business Square only in green; Stellantis on top	May. 13	AN
DIASORIN : Markets hailed the Q1 beat; guidance re-affirmed	May. 13
Mib only list in green; DiaSorin bullish	May. 13	AN
European shares listless as investors brace for inflation test	May. 13	RE
Mib opens slightly down but still runs DiaSorin	May. 13	AN
Europe's STOXX 600 opens higher as travel and leisure sector shines	May. 13	RE
Futures up slightly, focus is on results	May. 13	AN
Mib maglia rosa; accounts push DiaSorin up.	May. 10	AN
DiaSorin restarts buyback for maximum EUR	May. 10	AN
Milan top pink; accounts push DiaSorin	May. 10	AN
Transcript : DiaSorin S.p.A., Q1 2024 Earnings Call, May 10, 2024	May. 10
DiaSorin confirms annual guidance after quarterly results	May. 10	AN

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-06-05 - Jefferies Global Healthcare Conference

Related indices

STOXX EUROPE 600 (EUR) , FTSE MIB INDEX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

DIASORIN : Markets hailed the Q1 beat; guidance re-affirmed

May 13, 2024 at 09:36 am EDT

More Strategies

Ratings for DiaSorin S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

B

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

12

Last Close Price

98.94 EUR

Average target price

100.1 EUR

Spread / Average Target

+1.15%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
DIASORIN S.P.A.	+6.11%	5.72B
BIOMÉRIEUX	-3.43%	12.45B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-3.17%	8.22B
LANTHEUS HOLDINGS, INC.	+31.98%	5.67B
AUTOBIO DIAGNOSTICS CO., LTD.	-10.03%	4.11B
10X GENOMICS, INC.	-59.94%	2.68B
ANDON HEALTH CO., LTD.	+11.23%	2.68B
VITROLIFE AB	-5.14%	2.37B
MYRIAD GENETICS, INC.	+18.91%	2.06B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-7.56%	1.8B